Name: Septicemia Diagnostic Testing Market Size , Share , Growth Report 2023-2030
Creator: DataM Intelligence
Published: Wed Nov 20 2024 21:25:31 GMT+0530 (India Standard Time)
License: https://www.datamintelligence.com/terms-conditions

Septicemia Diagnostic Testing Market Size , Share , Growth Report 2023-2030

Septicemia Diagnostic Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Septicemia Diagnostic Testing Market&nbsp;is segmented&nbsp;By Product (Instruments, Blood Culture Media, Assay Kits and Reagents, Others), By Technology(Microbiology, Molecular Diagnostics, Immunoassays, Others), By Testing Type (Laboratory Testing, PoC Testing), &nbsp;By Pathogen(Bacterial Sepsis, Fungal Sepsis, Others), By End-User(Clinics, Diagnostic Centers, Others),&nbsp;and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029.</h2>&nbsp;<blockquote>Septicemia Diagnostic Testing Market&nbsp;is expected to reach&nbsp;at a <a target="_blank" rel="noopener noreferrer" href="https://www.datamintelligence.com/download-sample/septicemia-diagnostic-testing-market">CAGR of 13.5&nbsp;%</a> during the forecast period (2022-2029).</blockquote>Sepsis is a life-threatening organ dysfunction when the body's immune system attacks its organs and tissues in reaction to an infection. Chronic sickness, a weakened immune system, renal or liver disease, cancer, and serious wounds can all cause it. There is no confirmatory diagnostic test, and sepsis diagnosis requires clinical judgment based on infection and organ dysfunction evidence.Septicemia Diagnostic Testing Market<figure class="table"><table border="1" cellpadding="1" cellspacing="1"><tbody><tr><td>Metrics</td><td>Details</td></tr><tr><td>Market&nbsp;CAGR</td><td>13.5%</td></tr><tr><td>Segments Covered</td><td>By Product,&nbsp;By Technology,&nbsp;By Testing Type,&nbsp;By Pathogen,&nbsp;By End-user, and By Region</td></tr><tr><td>Report Insights Covered</td><td>Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.</td></tr><tr><td>Fastest Growing Region</td><td>Asia Pacific</td></tr><tr><td>Largest Market Share&nbsp;</td><td>North America</td></tr></tbody></table></figure><h3>Septicemia Diagnostic Testing Market Dynamics</h3>Novel technologies for the diagnosis of sepsis are expected to drive market growth.Nanotechnology-based solutions for clinical difficulties are becoming more widely used, opening up new possibilities in diagnosing and managing critical illnesses, including infections induced by bacteria resistant to antibiotics. Changing the antimicrobial discipline is frequently used in sepsis management for diagnostic, prognostic, monitoring, surrogate, and stratification purposes. Nanotechnology-based biosensors offer a revolutionary diagnostic technique that improves biomarker sensitivity and processing speed without professional abilities. For instance, a few biomarkers, such as CRP, PCT, and Interleukin-6, have been helpful in the clinical diagnosis of sepsis. Moreover, biomarkers have established a new paradigm for developing novel biosensors that can detect the presence of any biomarker in a variety of biological media, including whole blood, plasma, serum, cellular fluid, and others.<h3>COVID-19 Impact Analysis</h3>The SARS-CoV-2 pandemic resulted in a near-global lockdown and moderately influenced the septicemia diagnostic testing industry. One of the primary causes of death in COVID-19 patients is sepsis, which leads to multiorgan failure. The activation of the coagulation system in advanced or severe SARS-CoV-2 infection has been studied in several investigations. Sepsis has a significant mortality rate, showing that it is still one of the leading causes of death worldwide. Sepsis can be caused by various pathogens, including bacteria, fungi, and viruses. Even though bacterial infections were the most common cause of sepsis in these patients, clinical study and identification of viral sepsis are still uncommon. As a result, diagnosis is essential in a pandemic situation where no viable medication for the disease is available on the market.Additionally, the market faces challenges in manufacturing and delivering testing kits due to an interrupted supply chain. Providing essential services due to lockdowns has reduced supply to the end-users. The pandemic is not likely to have long-term effects on end-users primary growth in the septicemia diagnostic testing market.<h3>Septicemia Diagnostic Testing Market Segment Analysis</h3>Blood Culture Media segment is expected to hold the largest market share in septicemia diagnostic testing market.The blood culture media segment accounted for the largest market share in 2020. It is because blood culture is considered the most convenient and cost-effective mode of testing by clinicians. Moreover, blood tests reveal a lot of information about the body to healthcare providers, ranging from the possibility of infection to the functioning of the body's organs. These are some of the more typical blood tests performed on sepsis-like signs and symptoms patients. None of these tests can diagnose sepsis, but they can assist a doctor in diagnosing it when the results are paired with information about the condition and a physical examination.For instance, A complete blood count is a standard blood test. It determines, among other things, how many white blood cells are circulating in the circulation. White blood cells (also known as leukocytes) combat bacteria, viruses, and other harmful organisms in the body. A patient with a higher-than-average number of white blood cells (WBCs) in the blood may become infected. However, a low number of WBCs can suggest that the patient is at risk of infection. As a result of the above assertions, the market is predicted to grow in the forecast years.<h3>Septicemia Diagnostic Testing Market Geographical Analysis</h3>North America region holds the largest market share in the global septicemia diagnostic testing marketIn 2020, North America accounted for the highest revenue share. The incidence of sepsis cases in the United States increases every year due to factors such as an aging population, infections resistant to antibiotics, and higher sepsis risks among persons who have had an organ transplant. For instance, according to the Centers for Disease Control and Prevention (CDC), sepsis has a prevalence of 535 cases per 100,000 person-years in the United States and is on the rise. Moreover, the National Institutes of Health (NIH) funds sepsis research that assesses alternative therapeutic options. The CDC has started a public awareness campaign called "Get Ahead of Sepsis," which aims to protect Americans against the effects of sepsis. This campaign encourages healthcare providers to educate patients, prevent infections, recognize and diagnose sepsis early, and begin treatment as soon as possible.In addition, the region's well-established healthcare infrastructure has resulted in a rise in modern diagnostic solutions. Furthermore, large competitors on the ground and a favorable reimbursement system in this region encourage market expansion in the forecast period.<h3>Septicemia Diagnostic Testing Market Competitive Landscape</h3>Major key players in the septicemia diagnostic testing market are Diasorin, Abbott, F. Hoffmann-LA Roche Ltd, bioMérieux SA, Becton, Dickinson, and Company, Bruker Corporation, Luminex Corporation, Beckman Coulter, Inc.&nbsp;&nbsp; and McKesson. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which contribute to the global growth of the septicemia diagnostic testing market. For instance, Cytovale Inc. and the Biomedical Advanced Research and Development Authority, or BARDA, announced cooperation in April 2020 to increase the use of Cytovale's Rapid Sepsis Diagnostic System for identifying sepsis in patients with probable respiratory infections, such as COVID-19.<h3 style="background-color:#eeeeee;border:1px solid #cccccc;padding:5px 10px;">Frequently Asked Questions</h3>What is the Projected CAGR value of the Septicemia Diagnostic Testing Market?Septicemia Diagnostic Testing Market is expected to grow at a&nbsp;CAGR of 13.5%&nbsp;during the forecasting period 2022-2029.Which region controlled the global market during 2022-2029?North America&nbsp;region Controls&nbsp;the&nbsp;Septicemia Diagnostic Testing Market&nbsp;during 2022-2029Which is the fastest growing region in the Septicemia Diagnostic Testing Market?Among all regions,&nbsp;Asia Pacific&nbsp;is the fastest growing market share during the forecast period<h3 style="background-color:#eeeeee;border:1px solid #cccccc;padding:5px 10px;">Trending Topics</h3><a target="_blank" rel="noopener noreferrer" href="https://www.datamintelligence.com/research-report/nuclear-imaging-market">Nuclear Imaging Market</a><a target="_blank" rel="noopener noreferrer" href="https://www.datamintelligence.com/research-report/vascular-imaging-market">Vascular Imaging Market</a><a target="_blank" rel="noopener noreferrer" href="https://www.datamintelligence.com/research-report/veterinary-imaging-market">Veterinary Imaging Market</a>

<h2 style="background-color:#eeeeee;border:1px solid #cccccc;padding:5px 10px;">Table of Contents</h2><ol><li><h3>Methodology and Scope</h3><ol><li>Research Methodology</li><li>Research Objective and Scope of the Report</li></ol></li><li><h3>Market Definition and Overview</h3></li><li><h3>Executive Summary</h3><ol><li>Market Snippet by Product</li><li>Market Snippet by Technology</li><li>Market Snippet by Testing type</li><li>Market Snippet by Pathogen</li><li>Market Snippet by End user</li><li>Market Snippet by Region</li></ol></li><li><h3>Market Dynamics</h3><ol><li>Market Impacting Factors<ol><li>Drivers<ol><li>Novel technologies for the diagnosis of sepsis are expected to drive market growth.</li></ol></li><li>Restraints:<ol><li>The high cost of automated diagnostic instruments is expected to hamper the market growth.</li></ol></li><li>Opportunity</li><li>Impact Analysis</li></ol></li></ol></li><li><h3>Industry Analysis</h3><ol><li>Porter's Five Forces Analysis</li><li>Supply Chain Analysis</li><li>Pricing Analysis</li><li>Regulatory Analysis</li><li>Reimbursement Analysis</li><li>Unmet Needs</li></ol></li><li><h3>COVID-19 Analysis</h3><ol><li>Analysis of Covid-19 on the Market<ol><li>Before COVID-19 Market Scenario</li><li>Present COVID-19 Market Scenario</li><li>After COVID-19 or Future Scenario</li></ol></li><li>Pricing Dynamics Amid Covid-19</li><li>Demand-Supply Spectrum</li><li>Government Initiatives Related to the Market During Pandemic</li><li>Manufacturers Strategic Initiatives</li><li>Conclusion </li><li>Others</li></ol></li><li><h3>By Product</h3><ol><li>Introduction<ol><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Attractiveness Index, By Product Segment</li></ol></li><li>Instruments*<ol><li>Introduction</li><li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li></ol></li><li>Blood Culture Media</li><li>Assay Kits and Reagents</li><li>Others</li></ol></li><li><h3>By Technology</h3><ol><li>Introduction<ol><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li><li>Market Attractiveness Index, By Technology Segment</li></ol></li><li>Microbiology*<ol><li>Introduction</li><li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li></ol></li><li>Molecular Diagnostics</li><li>Immunoassays</li><li>Others</li></ol></li><li><h3>By Testing Type&nbsp;</h3><ol><li>Introduction<ol><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing type</li><li>Market Attractiveness Index, By Testing type Segment</li></ol></li><li>Laboratory Testing*<ol><li>Introduction</li><li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li></ol></li><li>PoC Testing</li></ol></li><li><h3>By Pathogen</h3><ol><li>Introduction<ol><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathogen</li><li>Market Attractiveness Index, By Pathogen Segment</li></ol></li><li>Bacterial Sepsis*<ol><li>Introduction</li><li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li></ol></li><li>Fungal Sepsis</li><li>Others</li></ol></li><li><h3>By End-user</h3><ol><li>Introduction<ol><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user</li><li>Market Attractiveness Index, By End-user Segment</li></ol></li><li>Clinics*<ol><li>Introduction</li><li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li></ol></li><li>Diagnostic Centers</li><li>Others</li></ol></li><li><h3>By Region</h3><ol><li>Introduction<ol><li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region</li><li>Market Attractiveness Index, By Region</li></ol></li><li>North America<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing type</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathogen</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country<ol><li>U.S.</li><li>Canada</li><li>Mexico</li></ol></li></ol></li><li>Europe<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing type</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathogen</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country<ol><li>Germany</li><li>U.K.</li><li>France</li><li>Italy</li><li>Spain</li><li>Rest of Europe</li></ol></li></ol></li><li>South America<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing type</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathogen</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country<ol><li>Brazil</li><li>Argentina</li><li>Rest of South America</li></ol></li></ol></li><li>Asia Pacific<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing type</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathogen</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country<ol><li>China</li><li>India</li><li>Japan</li><li>Australia</li><li>Rest of Asia Pacific</li></ol></li></ol></li><li>Middle East and Africa<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing type</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pathogen</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li></ol></li></ol></li><li><h3>Competitive Landscape</h3><ol><li>Key Developments and Strategies</li><li>Company Share Analysis</li><li>Product Benchmarking</li><li>List of Key Companies to Watch</li><li>List of Company with disruptive technology</li></ol></li><li><h3>Company Profiles</h3><ol><li>Diasorin*<ol><li>Company Overview</li><li>Product Portfolio and Description</li><li>Key Highlights</li><li>Financial Overview</li></ol></li><li>Abbott&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </li><li>F. Hoffmann-LA Roche Ltd&nbsp;&nbsp;&nbsp;&nbsp; </li><li>bioMérieux SA&nbsp;&nbsp;&nbsp;&nbsp; </li><li>Becton, Dickinson, and Company&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </li><li>Bruker Corporation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </li><li>Luminex Corporation&nbsp;&nbsp;&nbsp;&nbsp; </li><li>Beckman Coulter, Inc.&nbsp;&nbsp; </li><li>McKesson (*LIST NOT EXHAUSTIVE)</li></ol></li><li>DataM Intelligence<ol><li>Appendix</li><li>About Us</li><li>Contact Us</li></ol></li></ol>

<h2 style="background-color:#eeeeee;border:1px solid #cccccc;padding:5px 10px;">List of Tables &amp; Figures</h2>List of TablesTable1 Global Septicemia Diagnostic Testing Market Value, By Product, 2021, 2025 &amp; 2029 ($ Million)Table2 Global Septicemia Diagnostic Testing Market Value, By Technology, 2021, 2025 &amp; 2029 ($ Million)Table3 Global Septicemia Diagnostic Testing Market Value, By Testing Type, 2021, 2025 &amp; 2029 ($ Million)Table4 Global Septicemia Diagnostic Testing Market Value, By Pathogen, 2021, 2025 &amp; 2029 ($ Million)Table5 Global Septicemia Diagnostic Testing Market Value, By End user, 2021, 2025 &amp; 2029 ($ Million)Table6 Global Septicemia Diagnostic Testing Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)Table7 Global Septicemia Diagnostic Testing Market Value, By Product, 2021, 2025 &amp; 2029 ($ Million)Table8 Global Septicemia Diagnostic Testing Market Value, By Product, 2019-2029 ($ Million)Table9 Global Septicemia Diagnostic Testing Market Value, By Technology, 2021, 2025 &amp; 2029 ($ Million)Table10 Global Septicemia Diagnostic Testing Market Value, By Technology, 2019-2029 ($ Million)Table11 Global Septicemia Diagnostic Testing Market Value, By Testing Type, 2021, 2025 &amp; 2029 ($ Million)Table12 Global Septicemia Diagnostic Testing Market Value, By Testing Type, 2019-2029 ($ Million)Table13 Global Septicemia Diagnostic Testing Market Value, By Pathogen, 2021, 2025 &amp; 2029 ($ Million)Table14 Global Septicemia Diagnostic Testing Market Value, By Pathogen, 2019-2029 ($ Million)Table15 Global Septicemia Diagnostic Testing Market Value, By End user, 2021, 2025 &amp; 2029 ($ Million)Table16 Global Septicemia Diagnostic Testing Market Value, By End user, 2019-2029 ($ Million)Table17 Global Septicemia Diagnostic Testing Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)Table18 Global Septicemia Diagnostic Testing Market Value, By Region, 2019-2029 ($ Million)Table19 North America Septicemia Diagnostic Testing Market Value, By Product, 2019-2029 ($ Million)Table20 North America Septicemia Diagnostic Testing Market Value, By Technology, 2019-2029 ($ Million)Table21 North America Septicemia Diagnostic Testing Market Value, By Testing Type, 2019-2029 ($ Million)Table22 North America Septicemia Diagnostic Testing Market Value, By Pathogen, 2019-2029 ($ Million)Table23 North America Septicemia Diagnostic Testing Market Value, By End user, 2019-2029 ($ Million)Table24 North America Septicemia Diagnostic Testing Market Value, By Country, 2019-2029 ($ Million)Table25 South America Septicemia Diagnostic Testing Market Value, By Product, 2019-2029 ($ Million)Table26 South America Septicemia Diagnostic Testing Market Value, By Technology, 2019-2029 ($ Million)Table27 South America Septicemia Diagnostic Testing Market Value, By Testing Type, 2019-2029 ($ Million)Table28 South America Septicemia Diagnostic Testing Market Value, By Pathogen, 2019-2029 ($ Million)Table29 South America Septicemia Diagnostic Testing Market Value, By End user, 2019-2029 ($ Million)Table30 South America Septicemia Diagnostic Testing Market Value, By Country, 2019-2029 ($ Million)Table31 Europe Septicemia Diagnostic Testing Market Value, By Product, 2019-2029 ($ Million)Table32 Europe Septicemia Diagnostic Testing Market Value, By Technology, 2019-2029 ($ Million)Table33 Europe Septicemia Diagnostic Testing Market Value, By Testing Type, 2019-2029 ($ Million)Table34 Europe Septicemia Diagnostic Testing Market Value, By Pathogen, 2019-2029 ($ Million)Table35 Europe Septicemia Diagnostic Testing Market Value, By End user, 2019-2029 ($ Million)Table36 Europe Septicemia Diagnostic Testing Market Value, By Country, 2019-2029 ($ Million)Table37 Asia-Pacific Septicemia Diagnostic Testing Market Value, By Product, 2019-2029 ($ Million)Table38 Asia-Pacific Septicemia Diagnostic Testing Market Value, By Technology, 2019-2029 ($ Million)Table39 Asia-Pacific Septicemia Diagnostic Testing Market Value, By Testing Type, 2019-2029 ($ Million)Table40 Asia-Pacific Septicemia Diagnostic Testing Market Value, By Pathogen, 2019-2029 ($ Million)Table41 Asia-Pacific Septicemia Diagnostic Testing Market Value, By End user, 2019-2029 ($ Million)Table42 Asia-Pacific Septicemia Diagnostic Testing Market Value, By Country, 2019-2029 ($ Million)Table43 Middle East &amp; Africa Septicemia Diagnostic Testing Market Value, By Product, 2019-2029 ($ Million)Table44 Middle East &amp; Africa Septicemia Diagnostic Testing Market Value, By Technology, 2019-2029 ($ Million)Table45 Middle East &amp; Africa Septicemia Diagnostic Testing Market Value, By Testing Type, 2019-2029 ($ Million)Table46 Middle East &amp; Africa Septicemia Diagnostic Testing Market Value, By Pathogen, 2019-2029 ($ Million)Table47 Middle East &amp; Africa Septicemia Diagnostic Testing Market Value, By End user, 2019-2029 ($ Million)Table48 Diasorin: OverviewTable49 Diasorin: Product PortfolioTable50 Diasorin: Key DevelopmentsTable51 Abbott: OverviewTable52 Abbott: Product PortfolioTable53 Abbott: Key DevelopmentsTable54 F. Hoffmann-LA Roche Ltd: OverviewTable55 F. Hoffmann-LA Roche Ltd: Product PortfolioTable56 F. Hoffmann-LA Roche Ltd: Key DevelopmentsTable57 bioMérieux SA: OverviewTable58 bioMérieux SA: Product PortfolioTable59 bioMérieux SA: Key DevelopmentsTable60 Becton, Dickinson, and Company: OverviewTable61 Becton, Dickinson, and Company: Product PortfolioTable62 Becton, Dickinson, and Company: Key DevelopmentsTable63 Bruker Corporation: OverviewTable64 Bruker Corporation: Product PortfolioTable65 Bruker Corporation: Key DevelopmentsTable66 Luminex Corporation: OverviewTable67 Luminex Corporation: Product PortfolioTable68 Luminex Corporation: Key DevelopmentsTable69 Beckman Coulter, Inc.: OverviewTable70 Beckman Coulter, Inc.: Product PortfolioTable71 Beckman Coulter, Inc.: Key DevelopmentsTable72 McKesson: OverviewTable73 McKesson: Product PortfolioTable74 McKesson: Key DevelopmentsList of FiguresFigure1 Global Septicemia Diagnostic Testing Market Share, By Product, 2021 &amp; 2029 (%)Figure2 Global Septicemia Diagnostic Testing Market Share, By Technology, 2021 &amp; 2029 (%)Figure3 Global Septicemia Diagnostic Testing Market Share, By Testing Type, 2021 &amp; 2029 (%)Figure4 Global Septicemia Diagnostic Testing Market Share, By Pathogen, 2021 &amp; 2029 (%)Figure5 Global Septicemia Diagnostic Testing Market Share, By End user, 2021 &amp; 2029 (%)Figure6 Global Septicemia Diagnostic Testing Market Share, By Region, 2021 &amp; 2029 (%)Figure7 Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure8 Global Septicemia Diagnostic Testing Market Y-o-Y Growth, By Product, 2021-2029 (%)Figure9 Instruments: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure10 Blood Culture Media: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure11 Assay Kits and Reagents: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure12 Others: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure13 Global Septicemia Diagnostic Testing Market Y-o-Y Growth, By Technology, 2021-2029 (%)Figure14 Microbiology: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure15 Molecular Diagnostics: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure16 Immunoassays: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure17 Others: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure18 Global Septicemia Diagnostic Testing Market Y-o-Y Growth, By Testing Type, 2021-2029 (%)Figure19 Laboratory Testing: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure20 PoC Testing: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure21 Global Septicemia Diagnostic Testing Market Y-o-Y Growth, By Pathogen, 2021-2029 (%)Figure22 Bacterial Sepsis: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure23 Fungal Sepsis: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure24 Others: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure25 Global Septicemia Diagnostic Testing Market Y-o-Y Growth, By End user, 2021-2029 (%)Figure26 Clinics: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure27 Diagnostic Centers: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure28 Others: Global Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure29 Global Septicemia Diagnostic Testing Market Y-o-Y Growth, By Region, 2021-2029 (%)Figure30 North America Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure31 North America Septicemia Diagnostic Testing Market Share, By Product, 2021 &amp; 2029 (%)Figure32 North America Septicemia Diagnostic Testing Market Share, By Technology, 2021 &amp; 2029 (%)Figure33 North America Septicemia Diagnostic Testing Market Share, By Testing Type, 2021 &amp; 2029 (%)Figure34 North America Septicemia Diagnostic Testing Market Share, By Pathogen, 2021 &amp; 2029 (%)Figure35 North America Septicemia Diagnostic Testing Market Share, By End user, 2021 &amp; 2029 (%)Figure36 North America Septicemia Diagnostic Testing Market Share, By Country, 2021 &amp; 2029 (%)Figure37 South America Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure38 South America Septicemia Diagnostic Testing Market Share, By Product, 2021 &amp; 2029 (%)Figure39 South America Septicemia Diagnostic Testing Market Share, By Technology, 2021 &amp; 2029 (%)Figure40 South America Septicemia Diagnostic Testing Market Share, By Testing Type, 2021 &amp; 2029 (%)Figure41 South America Septicemia Diagnostic Testing Market Share, By Pathogen, 2021 &amp; 2029 (%)Figure42 South America Septicemia Diagnostic Testing Market Share, By End user, 2021 &amp; 2029 (%)Figure43 South America Septicemia Diagnostic Testing Market Share, By Country, 2021 &amp; 2029 (%)Figure44 Europe Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure45 Europe Septicemia Diagnostic Testing Market Share, By Product, 2021 &amp; 2029 (%)Figure46 Europe Septicemia Diagnostic Testing Market Share, By Technology, 2021 &amp; 2029 (%)Figure47 Europe Septicemia Diagnostic Testing Market Share, By Testing Type, 2021 &amp; 2029 (%)Figure48 Europe Septicemia Diagnostic Testing Market Share, By Pathogen, 2021 &amp; 2029 (%)Figure49 Europe Septicemia Diagnostic Testing Market Share, By End user, 2021 &amp; 2029 (%)Figure50 Europe Septicemia Diagnostic Testing Market Share, By Country, 2021 &amp; 2029 (%)Figure51 Asia-Pacific Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure52 Asia-Pacific Septicemia Diagnostic Testing Market Share, By Product, 2021 &amp; 2029 (%)Figure53 Asia-Pacific Septicemia Diagnostic Testing Market Share, By Technology, 2021 &amp; 2029 (%)Figure54 Asia-Pacific Septicemia Diagnostic Testing Market Share, By Testing Type, 2021 &amp; 2029 (%)Figure55 Asia-Pacific Septicemia Diagnostic Testing Market Share, By Pathogen, 2021 &amp; 2029 (%)Figure56 Asia-Pacific Septicemia Diagnostic Testing Market Share, By End user, 2021 &amp; 2029 (%)Figure57 Asia-Pacific Septicemia Diagnostic Testing Market Share, By Country, 2021 &amp; 2029 (%)Figure58 Middle East &amp; Africa Septicemia Diagnostic Testing Market Value, 2019-2029 ($ Million)Figure59 Middle East &amp; Africa Septicemia Diagnostic Testing Market Share, By Product, 2021 &amp; 2029 (%)Figure60 Middle East &amp; Africa Septicemia Diagnostic Testing Market Share, By Technology, 2021 &amp; 2029 (%)Figure61 Middle East &amp; Africa Septicemia Diagnostic Testing Market Share, By Testing Type, 2021 &amp; 2029 (%)Figure62 Middle East &amp; Africa Septicemia Diagnostic Testing Market Share, By Pathogen, 2021 &amp; 2029 (%)Figure63 Middle East &amp; Africa Septicemia Diagnostic Testing Market Share, By End user, 2021 &amp; 2029 (%)Figure64 Diasorin: FinancialsFigure65 Abbott: FinancialsFigure66 F. Hoffmann-LA Roche Ltd: FinancialsFigure67 bioMérieux SA: FinancialsFigure68 Becton, Dickinson, and Company: FinancialsFigure69 Bruker Corporation: FinancialsFigure70 Luminex Corporation: FinancialsFigure71 Beckman Coulter, Inc.: FinancialsFigure72 McKesson: Financials